title: Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
abstract: With the constant advent of new developments and modifications in immunosuppressive regimens, clinicians are responsible for providing pregnancy counseling in all pre and post-transplant patients of childbearing age. As individual physicians and centers accrue experience with these major therapeutic decisions, it is critical that both positive and negative outcomes be reported in appropriate settings-symposia, meetings, publications, and registries. Future analyses from the NTPR are directed at potential effects of newer immunosuppressive regimens, not only from immediate exposure, but also from continued exposures such as may occur from breastfeeding. As the registry study design allows for contact between registry staff and recipients and their health care providers, efforts are ongoing to analyze long-term outcomes of parent and child. Continued close collaboration among specialists will help to identify potential pregnancy risks in these populations, particularly as new immunosuppressive agents are developed. Therefore, centers are encouraged to report all pregnancy exposures in transplant recipients to the NTPR. The 50th anniversary of the first post-transplant pregnancy (reported by Joseph Murray et al. (32)) that occurred in March of 2008 helped to raise awareness of the need for continued worldwide cooperation for data collection. Enhanced assessment of pregnancy safety is essential to the development of guidelines for counseling and management of pregnancy in the transplant population.
authors.affiliation: Dept of Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Coscia
authors.forename: Serban
authors.initials: S
authors.lastname: Constantinescu
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Moritz
authors.forename: Adam M
authors.initials: AM
authors.lastname: Frank
authors.forename: Carlo B
authors.initials: CB
authors.lastname: Ramirez
authors.forename: Cataldo
authors.initials: C
authors.lastname: Doria
authors.forename: Carolyn H
authors.initials: CH
authors.lastname: McGrory
authors.forename: Vincent T
authors.initials: VT
authors.lastname: Armenti
mesh_terms: D003376:Counseling; D005260:Female; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D016377:Organ Transplantation / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology*; D011256:Pregnancy Outcome; D012042:Registries; D018570:Risk Assessment; D011795:Surveys and Questionnaires; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
chemical_list: D007166:Immunosuppressive Agents